Correlation Between Neuropace and Glaukos Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Glaukos Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Glaukos Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Glaukos Corp, you can compare the effects of market volatilities on Neuropace and Glaukos Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Glaukos Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Glaukos Corp.

Diversification Opportunities for Neuropace and Glaukos Corp

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Neuropace and Glaukos is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Glaukos Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Glaukos Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Glaukos Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Glaukos Corp has no effect on the direction of Neuropace i.e., Neuropace and Glaukos Corp go up and down completely randomly.

Pair Corralation between Neuropace and Glaukos Corp

Given the investment horizon of 90 days Neuropace is expected to under-perform the Glaukos Corp. In addition to that, Neuropace is 1.79 times more volatile than Glaukos Corp. It trades about -0.17 of its total potential returns per unit of risk. Glaukos Corp is currently generating about -0.12 per unit of volatility. If you would invest  13,539  in Glaukos Corp on June 29, 2024 and sell it today you would lose (698.00) from holding Glaukos Corp or give up 5.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Glaukos Corp

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neuropace has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Neuropace is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Glaukos Corp 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Glaukos Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Glaukos Corp may actually be approaching a critical reversion point that can send shares even higher in October 2024.

Neuropace and Glaukos Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Glaukos Corp

The main advantage of trading using opposite Neuropace and Glaukos Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Glaukos Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glaukos Corp will offset losses from the drop in Glaukos Corp's long position.
The idea behind Neuropace and Glaukos Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges